Stock Events

Stock Events

Verrica Pharmaceuticals (VRCA) Q2 2026 Earnings

12MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-1.26

-0.83

-0.41

0.02

Details

Expected EPS

-0.419775

Actual EPS

-0.45

Surprise EPS

-0.03

Surprise Percent

+7.2%

Description

Verrica Pharmaceuticals (VRCA) has reported earnings of -0.45 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.